Objectives

After participating in this educational activity, attendees should be able to:
1| Describe the risk and the pathophysiology of VTE following total knee or hip arthroplasty.

2| Identify current practices for VTE prophylaxis following joint replacement

3| Evaluate the findings of the EPCAT III trial and discuss the use of aspirin use in certain patient populations.

Presenter(s): 
Adela Storey, PharmD
PGY1 Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Adela Storey, PharmDSpeakerNo relevant relationships with ineligible companies to discloseNo
Session date: 
10/19/2026 - 2:00pm to 2:30pm EDT
Location: 
Hybrid
United States
See map: Google Maps
Add to calendar: 
  • 0.50 ACPE Contact Hours
  • 0.50 ACPE Technician contact hours
Please login or register to take this course.